Literature DB >> 18679415

Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.

D W Müller1, A-K Bosserhoff.   

Abstract

Although integrin beta(3) is known to play an important role in melanoma progression and invasion, regulation of integrin beta(3) expression in melanoma has not been analysed in detail until today. As transcriptional regulation of integrin beta(3) was ruled out by our analysis, we concentrated on the regulation by microRNAs (miRNAs). Comparing primary melanocytes and malignant melanoma cell lines, we found that one candidate miRNA, miR-let-7a, was lost in melanoma and sequence analysis suggested an interaction with the 3'-untranslated region (3'-UTR) of integrin beta(3) mRNA. Transfection of melanoma cells with let-7a pre-miR(TM) molecules resulted in the downregulation of integrin beta(3) mRNA and protein expression. In addition, we cloned the 3'-UTR of the integrin beta(3) mRNA containing the let-7a target sequence into a reporter plasmid and revealed that let-7a negatively regulates reporter gene expression. The repressed expression of integrin beta(3) accompanies with reduced invasive potential of melanoma cells transfected with synthetic let-7a molecules observed in Boyden chamber assays. On the other hand, the induction of integrin beta(3) expression was achieved in melanocytes by transfection with let-7a anti-miRs, resulting in invasive behavior of transfected melanocytes. In summary, we determined miRNA let-7a to be an important regulator of integrin beta(3) expression and showed that the loss of let-7a expression is involved in development and progression of malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18679415     DOI: 10.1038/onc.2008.282

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  75 in total

Review 1.  MicroRNAs in skin and wound healing.

Authors:  Jaideep Banerjee; Yuk Cheung Chan; Chandan K Sen
Journal:  Physiol Genomics       Date:  2010-10-19       Impact factor: 3.107

2.  Melanoma MicroRNA signature predicts post-recurrence survival.

Authors:  Miguel F Segura; Ilana Belitskaya-Lévy; Amy E Rose; Jan Zakrzewski; Avital Gaziel; Douglas Hanniford; Farbod Darvishian; Russell S Berman; Richard L Shapiro; Anna C Pavlick; Iman Osman; Eva Hernando
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

Review 3.  Pivotal MicroRNAs in Melanoma: A Mini-Review.

Authors:  Zhenjun Deng; Jingang Hao; Dongyun Lei; Yongjing He; Lechun Lu; Li He
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

4.  MicroRNA expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues.

Authors:  Aihua Liu; Michael T Tetzlaff; Pat Vanbelle; David Elder; Michael Feldman; John W Tobias; Antonia R Sepulveda; Xiaowei Xu
Journal:  Int J Clin Exp Pathol       Date:  2009-03-20

Review 5.  The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.

Authors:  Muhammad Nauman Aftab; Marcel E Dinger; Ranjan J Perera
Journal:  Arch Biochem Biophys       Date:  2014-07-24       Impact factor: 4.013

6.  Acrolein decreases endothelial cell migration and insulin sensitivity through induction of let-7a.

Authors:  Timothy E O'Toole; Wesley Abplanalp; Xiaohong Li; Nigel Cooper; Daniel J Conklin; Petra Haberzettl; Aruni Bhatnagar
Journal:  Toxicol Sci       Date:  2014-05-08       Impact factor: 4.849

Review 7.  miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.

Authors:  Paige E Bennett; Lynne Bemis; David A Norris; Yiqun G Shellman
Journal:  Physiol Genomics       Date:  2013-09-17       Impact factor: 3.107

8.  The metastasis suppressor NME1 inhibits melanoma cell motility via direct transcriptional induction of the integrin beta-3 gene.

Authors:  M Kathryn Leonard; Marián Novak; Devin Snyder; Grace Snow; Nidhi Pamidimukkala; Joseph R McCorkle; Xiuwei H Yang; David M Kaetzel
Journal:  Exp Cell Res       Date:  2018-11-17       Impact factor: 3.905

Review 9.  MicroRNA-mediated control in the skin.

Authors:  R Yi; E Fuchs
Journal:  Cell Death Differ       Date:  2009-07-17       Impact factor: 15.828

Review 10.  Molecular and cellular pathogenesis of melanoma initiation and progression.

Authors:  Tarik Regad
Journal:  Cell Mol Life Sci       Date:  2013-03-27       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.